Bryan L E, Bedard J
Department of Microbiology, University of Calgary, Canada.
Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):232-9. doi: 10.1007/BF01966995.
The initial step in the accumulation of fluoroquinolone antimicrobial agents is binding to cell surface components reduced by lowered pH and divalent cations. Uptake into gram-negative and gram-positive bacteria is by simple diffusion. Entry through the outer membrane occurs preferentially for most agents by the porin route but a second process using the self-promoted uptake pathway is active especially for more hydrophobic agents. Fluoroquinolones bind to vesicles of phospholipid which may be the initiating step in cross-cytoplasmic membrane diffusion. An active efflux system has been described in Escherichia coli with evidence supporting its presence in several other bacteria. Total upset is not altered by a resistant gyrase. Resistant isolates associated with reduced total quinolone accumulation due to lowered uptake have been described for laboratory mutants and clinical isolates. Most but not all of these have had alterations in outer membrane proteins. A functionally dominant resistance gene has been cloned from resistant Staphylococcus aureus and codes for a highly hydrophobic protein most likely membrane associated. This gene is expressed in Escherichia coli and specifies resistance especially to hydrophilic quinolones, possibly by altered accumulation.
氟喹诺酮类抗菌剂积累的初始步骤是与因pH值降低和二价阳离子减少而减少的细胞表面成分结合。革兰氏阴性菌和革兰氏阳性菌通过简单扩散摄取。大多数药物优先通过孔蛋白途径穿过外膜,但第二个过程使用自我促进摄取途径,特别是对于疏水性更强的药物,该过程是活跃的。氟喹诺酮类药物与磷脂囊泡结合,这可能是跨细胞质膜扩散的起始步骤。在大肠杆菌中已描述了一种主动外排系统,有证据支持其在其他几种细菌中的存在。耐药性的gyrase不会改变总摄取量。对于实验室突变体和临床分离株,已描述了由于摄取降低导致喹诺酮类药物总积累减少的耐药分离株。其中大多数(但不是全部)外膜蛋白发生了改变。一个功能上占主导地位的耐药基因已从耐药金黄色葡萄球菌中克隆出来,编码一种高度疏水的蛋白质,很可能与膜相关。该基因在大肠杆菌中表达,尤其对亲水性喹诺酮类药物具有耐药性,可能是通过改变积累来实现的。